omega-3-acid ethyl esters

FDA Drug Profile — omega-3-acid ethyl esters, Omega-3-Acid Ethyl Ester

omega-3-acid ethyl esters is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including omega-3-acid ethyl esters, Omega-3-Acid Ethyl Ester. Available dosage forms: capsule, liquid filled, capsule, oil.

Drug Details

Generic Name
omega-3-acid ethyl esters
Brand Names
omega-3-acid ethyl esters, Omega-3-Acid Ethyl Ester
Application Number
ANDA203893
Sponsor
Patheon Softgels Inc
NDC Codes
10
Dosage Forms
CAPSULE, LIQUID FILLED, CAPSULE, OIL
Routes
ORAL
Active Ingredients
OMEGA-3-ACID ETHYL ESTERS

Indications and Usage

1 INDICATIONS AND USAGE Omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (greater than or equal to 500 mg/dL) hypertriglyceridemia. Usage Considerations: Patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters and should continue this diet during treatment with omega-3-acid ethyl esters capsules. Laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters. Every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. Medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed, if possible, prior to consideration of TG-lowering drug therapy. Limitations of Use: The effect of omega-3-acid ethyl esters capsules on the risk for pancreatitis has not been determined. The effect of omega-3-acid ethyl esters on cardiovascular mortality and morbidity has not been determined. Omega-3-acid ethyl esters capsules are a combination of ethyl esters of omega 3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. (1) Limitations of Use: The effect of omega-3-acid ethyl esters on the risk for pancreatitis has not been determined. (1) The effect of omega-3-acid ethyl esters on cardiovascular mortality and morbidity has not been determined. (1)